Indeed, as mentioned above, RNAseq of the skin of AD and PSO patients suffering from severe itch revealed that CB1 and CB2 were significantly down-regulated in both diseases indicating that loss of homeostatic cutaneous CB1/CB2 signaling may disease-independently contribute to the development of chronic itch [276]. Here, CNR2 is linked to Alzheimer disease.